ATLANTHERA DRUG DISCOVERY COMPANY

GET THE NEW THERAPY FOR BONE CANCER

Atlanthera is a drug discovery company focused on bone diseases and bone cancer treatments

Our vision: Be the leader in bone-targeted drug delivery to cure bone cancer and metastases

Atlanthera can rely on a very high-qualified Team and a worldwide-known experts network

Our concept: Bone-targeted delivery of anti-cancer drug

 

Our news
Bio Europe Spring 2020

BIO EUROPE SPRING – DIGITALLY DELIVERED – ATLANTHERA

Glad to attend Bio Europe Spring initially planned in Paris and now delivered digitally. Looking forward to fruitful dis [...]
Publication ODD ATA 2019

Orphan Drug Designation for our compound 12b80 in Osteosarcoma indication by EMA – Atlanthera

Our team is particularly proud and glad to announce the obtention of Orphan Drug Designation for our compound 12b80 in O [...]
BIO-Europe 2019

Bio Europe – Hamburg – November 2019

Our team will attend Bio Europe in Hamburg, Germany, from November 11th to 13th. Looking forward to discussing with you [...]

Meet Us

3 rue Aronnax
44821 Saint-Herblain Cedex
FRANCE

Contact Us

: +33 (0)2 51 78 98 76
: +33 (0)2 28 25 68 02
: Contact

Follow Us